University of Copenhagen Researchers Highlight Research in Mantle Cell Lymphoma (Concurrent Inhibition of Akt and ERK Using TIC-10 Can Overcome Venetoclax Resistance in Mantle Cell Lymphoma).

Předmět:	MANTLE cell lymphoma VENETOCLAX
Zdroj:	Drug Week; 2/10/2023, p3894-3894, 1p
Abstrakt:	Oncology - Mantle Cell Lymphoma Data detailed on Mantle cell lymphoma have been presented. Venetoclax-resistant cells also exhibited an upregulation ofthe PI3K/Akt pathway, and pharmacological inhibition of Akt and ERK withTIC-10 led to cell death in all venetoclax-resistant cell lines.". [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu